# Japanese BAY86-9766 Monotherapy Phase I Study

> **NCT01179295** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 12 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** BAY86-9766
- **DRUG:** BAY86-9766
- **DRUG:** BAY86-9766
- **DRUG:** BAY86-9766

## Key facts

- **NCT ID:** NCT01179295
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11-19
- **Primary completion:** 2012-04-27
- **Final completion:** 2012-04-27
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01179295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01179295, "Japanese BAY86-9766 Monotherapy Phase I Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01179295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*